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Abstract
Background: Myxofibrosarcoma is an aggressive soft tissue neoplasm, classified as a variant of malignant fibrous
histiocytoma. Most often, it occurs in middle to late adult life peaking in the seventh decade and involving the
lower extremities (77%), trunk (12%), and retroperitoneum or mediastinum (8%). We report the first case of thoracic
myxofibrosarcoma presenting as a Pancoast tumor.
Case presentation: A 48-year-old non-tobacco smoking African-American man presented with a slow-growing
mass in his neck along with 11 kg weight loss over 9 months. A review of his systems was positive for
hoarseness and lowgrade intermittent fever without any shortness of breath or cough. A physical examination
revealed a mass on the left side of his neck superior to his sternoclavicular joint measuring 3 × 3 × 1 cm.
He had ptosis and miosis of his left eye. His breath sounds were decreased and coarse at the left apex.
A neurological examination revealed 3/5 strength in his left upper arm. The remainder of the physical
examination was unremarkable.
Ultrasound of his neck showed an ill-defined heterogeneous mass lateral to his left thyroid lobe. A computed
tomography scan of his chest showed a large multiloculated pleural-based mass in his left lung surrounding
the adjacent neurovascular structures. A percutaneous biopsy was non-diagnostic. Subsequently, he underwent
a left thoracotomy with biopsy. The mass extended from his anterior mediastinum medially at the level of
the pulmonary trunk, superiorly into the superior sulcus and posteriorly into his chest wall. Surgical pathology
confirmed the diagnosis of myxofibrosarcoma.
Conclusions: Here we present a case of Pancoast tumor with myxofibrosarcoma as the underlying etiology.
Pancoast syndrome generally entails an infiltrating lesion in the superior sulcus presenting with upper
extremity pain, atrophy of the hand muscles, and Horner’s syndrome. The differential diagnosis of Pancoast
syndrome includes inflammatory and infectious etiologies, as well as neoplasms of benign and malignant
nature. Of the neoplasms implicated, the most common are non-small cell lung carcinomas;
myxofibrosarcoma presenting as a Pancoast tumor has not been reported in the literature.
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Background
Myxofibrosarcoma (MFS) is an aggressive soft tissue
neoplasm classified as a variant of malignant fibrous his-
tiocytoma (MFH). On histologic examination it is com-
posed of both fibroblastic and histiocytic elements. Most
cases occur in middle-to-late adult life with a peak
incidence in the seventh decade [1, 2]. They are
predominantly encountered in the lower extremities
(77%), trunk (12%), and retroperitoneum or mediasti-
num (8%) [1–3]. To the best of our knowledge only 19
cases of head and neck MFSs have been described in the
literature, making it exceedingly rare [1]. For these
sarcomas, the best approach to treatment is complete
surgical resection [1]. Of all case presentations, none
have had Pancoast syndrome as the initial manifestation.
We are reporting the first case of MFS presenting as a
Pancoast tumor.
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Pancoast syndrome involves an infiltrating mass at the
apex of the lung [4, 5]. Clinical manifestation is related
to lesion location in the superior sulcus, with ipsilateral
shoulder and arm pain, and weakness and atrophy of the
ipsilateral hand muscles all due to brachial plexus com-
pression or invasion. Commonly, Pancoast tumors also
exhibit concurrent Horner’s syndrome along with other
signs and symptoms of malignancy.
The majority of superior sulcus tumors are non-small
cell lung carcinomas (NSCLCs) [5, 6]. Other etiologies
less common for Pancoast syndrome include inflamma-
tory, infectious, and neoplastic entities [4–6]. The treat-
ment modalities for Pancoast tumor are determined by
the specific nature of the neoplastic process in question.
Surgical intervention is indicated in the majority of these
instances. The presence of Horner’s syndrome and
advanced disease are associated with a dire prognosis [4, 6].
Case presentation
A 48-year-old African-American man with no significant
tobacco history presented with a slow-growing mass in
his neck and 11 kg weight loss over a 9-month
period (Fig. 1). On further history, he reported left arm
pain and weakness, intermittent fever with chills, and
had denied any dyspnea, shortness of breath, or cough.
His past medical history was significant for diabetes mel-
litus, chronic obstructive pulmonary disease, and nerve
impingement of his left shoulder. On physical examin-
ation, a mass was noted on the left side of his neck just
superior to the sternoclavicular joint measuring 3 × 3 ×
1 cm. He had ptosis and miosis of his left eye. His speech
was hoarse, indicative of recurrent laryngeal nerve
involvement. His breath sounds were decreased and
coarse at the left apex. The strength of his extremities
exhibited 3/5 weakness in his left arm, with the remainder
of his limbs normal. There was positive muscle atrophy of
his left upper extremity. Otherwise, the remainder of the
physical examination was benign in nature.
An ultrasound performed on the neck mass showed
an ill-defined heterogeneous mass lateral to his left thy-
roid lobe, resulting in mild mass effect. Further investi-
gation was warranted with radiological studies including
chest X-rays and a computed tomography (CT) scan of
his chest. A chest X-ray exhibited a mass extending from
the hilum of his left lung with gross deviation of his tra-
chea and elevation of his hemidiaphragm. A CT scan of
his chest showed a large multiloculated pleural-based
mass in his lungs surrounding his left common carotid
artery, left subclavian artery, which interfaced broadly
with the aortic arch and extended into the left neurofor-
amina of C4/C5 through T1/T2 (Fig. 2).
Percutaneous needle core biopsy was performed on his
neck and showed fibrohistiocytic tissue with mild
chronic inflammation but was negative for malignancy.
A left thoracotomy with biopsy was performed of the
pleura and of the upper and middle lung lobes of his left
lung evidencing a mass extending from the anterior
mediastinum medially at the level of his pulmonary ar-
tery trunk superiorly into the superior sulcus and poster-
iorly into his chest wall. Tissue samples were obtained,
all demonstrating a gross appearance of a pink to yellow
gelatinous tissue for which frozen sectioning revealed
soft tissue malignancy. Hematoxylin and eosin staining
demonstrated a predominance of hyperchromatic
spindle-shaped cells with acidophil cytoplasm (Fig. 3).
This is consistent with high-grade sarcomas [7] typically
with disorganized pleomorphic cells that can also
include histiocytes and giant multinucleated cells [8]. A
panel of immunohistochemical stains was performed of
which only Wilms tumor protein (WT1), vimentin, and
Ki67 were positive. This finding ruled out carcinoma,
mesothelioma, melanoma, vascular tumor, synovial sar-
coma, and Kaposi’s sarcoma as possible etiologies. Over-
all, immunohistochemistry revealed a high-grade
undifferentiated myxoid sarcoma confirmed by the Mayo
Clinic as fibromyxosarcoma versus MFS.
Discussion
Head and neck presentation of MFS is extremely rare. To
the best of our knowledge, of the 19 cases of head and
neck MFS reported in the literature, our case is the first
presenting as a Pancoast tumor. Pancoast syndrome en-
tails superior sulcus infiltration presenting with upper ex-
tremity pain and atrophy of the hand muscles, commonly
with concurrent Horner’s syndrome [5, 6]. The differential
diagnosis of a Pancoast syndrome includes inflammatory
etiologies such as sarcoidosis and granulomatosis with
polyangiitis, infectious etiologies such as tuberculosis and
aspergillosis, and neoplasms of benign and malignant
nature [5, 6]. Of the neoplasms implicated, the most com-
mon are NSCLCs; MFS presenting as a Pancoast tumor
has not been reported in the literature [5].
MFS is characterized by nodular growth of spindle-
shaped or stellate-shaped fibroblastic cells in a myxoid
matrix [2, 9]. This entity has been divided into four
grades pertaining to cellularity, atypia, and extent of
myxoid component [1–3, 9]. High-grade MFS (HGMFS)
demonstrates a dominance of patternless histiocyte-like
cells with pleomorphism in a minimal myxoid matrix
[9]. Characteristic features differentiating this grade of
lesion include areas of necrosis with lymphocytic
infiltration, numerous and atypical mitotic figures, mul-
tinucleated giant cells, and extravasation of erythrocytes
[2, 3, 9]. HGMFS lesions are frequently encountered in
intramuscular and subfascial anatomy as opposed to the
superficial (subcutaneous or dermal) manifestations of
lower-grade lesions [2, 3, 9]. The differential diagnosis
for HGMFS includes lesions of lower grade, nodular
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fasciitis, myxoma, extraskeletal myxoid chondrosar-
coma, and pulmonary artery sarcomas [2, 3, 7, 10]. The
characteristic features of our case presentation favored
HGFMS as a diagnosis over other etiologies and lesions
of lower grade.
Mentzel, Angervall, Merck, and their colleagues have
previously described the relation between histologic
grade of MFS and rate of local recurrence [2, 9]. The
local recurrence of HGMFS had been documented as
55%, 64%, and 61% by Mentzel, Angervall, and Merck,
respectively [2, 9]. The patient in our case report did not
demonstrate any metastatic lesions. Mentzel, Angervall,
and Merck had similarly described metastatic rates as
29%, 27%, and 38%, respectively [2, 9]. HGMFS has a
less favorable outcome when compared to lower grades,
with a mean survival of 2 months without intervention
and extension to 10 months with tumor resection [11,
12]. As such, complete surgical resection is the mainstay
treatment for MFS. Unfortunately, there is little litera-
ture regarding combination radiochemotherapy for cases
of MFS that have suboptimal or no surgical excision [1,
13]. Although the tumor was evidently a suboptimal
January 2014
Does not visit primary care
physician due to symptoms.
September 2014
Refer to Fig. 2
Refer to Fig. 3
SYMPTOMS
Begins to experience intermittent 
chills with weight loss.
Patient is a 48-year-old African-
American male with insignificant 
tobacco history; medical history of 
DM, COPD
Admitted to the hospital via primary 
care physician due to worsening of 
symptoms. 
SYMPTOMS




• Neck mass measuring 
3x3x1 cm
• Hoarse speech
• Ptosis and miosis of left eye
• Coarse breath sounds at left 
lung apex
• Left upper extremity weakness 
and muscle atrophy
Ultrasound of the neck demonstrates 
ill-defined mass displacing thyroid 
gland.
Chest x-ray and CT scan of the 
chest performed for investigation.  
Inconclusive percutaneous needle 
core biopsy.
Left thoracotomy biopsy 
demonstrates extensive disease, 
only subtotal resection possible.  
Pathology: immunohistochemistry 
determines myxofibrosarcoma.
Complete resection not possible due 
to extensive nature of disease. 
Patient started on ifosfamide with 
radiation therapy with follow-up.
Fig. 1 Timeline of case presentation. COPD chronic obstructive pulmonary disease, CT computed tomography, DM diabetes mellitus
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candidate for complete surgical resection, less invasive
modalities of histological diagnosis were not employable.
Thus, a left thoracotomy was opted for with the goal of
definitive tissue diagnosis and resection of safely remov-
able tumor mass. Unfortunately, an insufficient margin
of resection was the result due to the extensive involve-
ment of critical structures. Mediastinal excision of the
mass measuring 6 × 6 cm was performed with partial
decortication. More studies are necessary to investigate
the efficacy of adjuvant radiochemotherapy for head and
neck MFS, with a focus on cases where surgical manage-
ment is difficult to attain. Although this entity is difficult
to treat, follow-up entails assessing symptom progres-
sion and serial imaging [1, 9, 13].
Our patient had requested transfer of care to an oncol-
ogy center with more proximity to his home address.
They had begun treatment with high-dose ifosfamide.
The first cycle of treatment was well tolerated, resulting
in an apparent decrease in tumor size. He had returned
for a second cycle of ifosfamide with an initial dose of
high-intensity radiation with the high-dose spatially-
fractionated radiation (GRID) approach followed by add-
itional doses with conventional radiation.
Conclusions
In conclusion, MFS is a relatively uncommon malig-
nancy and has not been described as a Pancoast tumor
in the medical literature. Surgical resection may result in
insufficient margins when extensive invasion within the
superior sulcus and critical structures of the thorax is
involved. Given that this management is the mainstay
for MFS, more research is necessary with regards to
adjuvant therapies that can improve prognosis.
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